Subjects who participated in an automated internet structured behavioral treatment program showed better weight losses…
Read More »Monthly Archives: January 2015
Beloranib Demonstrates Weight Loss in Hypothalamic Injury-Associated Obesity
The drug, a first-in-class MetAP2 inhibitor, was well-tolerated and also improved cardiovascular disease risk factors… Zafgen has announced that ZAF-221, a randomized, double-blind, placebo-controlled Phase 2 clinical trial of beloranib, a MetAP2 inhibitor, in 14 adults with hypothalamic injury associated obesity, or HIAO, met the primary efficacy endpoint of weight …
Read More »Type 2 Diabetes Increased Risk for Colorectal Cancer
Dutch researchers evaluated data on 300,039 type 2 adults on at least one prescription for an antidiabetes drug, and a comparison cohort without diabetes (controls) to determine the relationship between type 2 diabetes and colorectal cancer. “We observed a moderate, yet (1.3-fold) significantly increased, risk of colorectal cancer in patients …
Read More »Inactive Adults with Diabetes at Twice the Risk for First Acute MI
“The results from this study showed that inactive people with diabetes had a more than twofold increased risk of a first [acute] MI when compared with inactive people without diabetes,” the researchers wrote. “This excess risk was canceled out in people with diabetes who reported a high physical activity level. …
Read More »Women with PTSD Have Higher Risk for Type 2 Diabetes
In this 22-year study of women, symptoms of post-traumatic stress disorder (PTSD) were associated with the incidence of type 2 diabetes in a dose-dependent manner. The authors conclude that women with PTSD were at a twofold increased risk for having type 2 diabetes than counterparts without PTSD, and thus care …
Read More »Patient Handout – A Diabetes Glossary
When a patient is diagnosed with diabetes the first thing they will most likely do is go to the internet. This glossary, courtesy of dLife, will provide them the definitions for most of the medical terms they will see and make them more aware of their situation. Plus it will …
Read More »FDA Approves VBLOC Vagal Blocking Therapy for Weight Loss
VBLOC Therapy is a first-in-class weight loss treatment that addresses the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. Therapy is delivered by a pacemaker-like device called the Maestro® Rechargeable System controls both hunger and fullness by blocking the primary nerve which regulates …
Read More »t:flex Insulin Pump Cleared by FDA
The t:flex Pump is designed for patients who require more than 100 units of U-100 insulin per day, such as teenagers with type 1 diabetes and many people with type 2 diabetes. The pump offers the benefits of pump therapy without the frequent reservoir changes required by 200- and …
Read More »Letter from the Editor, #764
This was a particularly aggravating week for both my patients and insurance companies. The new year has brought copays and deductibles to many of my Part D patients. Most of them had no idea that they now had a $200 deductible and swore that their plan did not tell them …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 14
In this week’s Homerun Slides, we focus in on the specifics of the drug, Ranolazine, which is used to treat angina, and its effects on patients with diabetes… To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part 14 Other sets in this series: Diabetes Mellitus …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.